The trademark application Glemway was filed by Novo Nordisk A/S, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). The application was published for oppositions on October 20, 2024, and still open for oppositions.
The application was filed in Danish (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations for the treatment of diabetes
Pharmaceutical preparations for weight reduction and long term weight loss maintenance
Pharmaceutical preparations for the treatment of cardiovascular diseases..